Literature DB >> 10335688

Clustering of metabolic factors and coronary heart disease.

P W Wilson1, W B Kannel, H Silbershatz, R B D'Agostino.   

Abstract

BACKGROUND: The degree of clustering for common metabolic coronary disease risk factors is not well known, the antecedents of clustering are not well studied, and the impact of such clusters on coronary risk has not been assessed systematically.
METHODS: Prospective community sample of 2406 men and 2569 women aged 18 to 74 years at baseline. The 6 metabolically linked risk factors considered were the lowest sex-specific quintile of high-density lipoprotein cholesterol and the highest quintiles of body mass index, systolic blood pressure, triglycerides, glucose, and serum total cholesterol.
RESULTS: At baseline the risk factor sum, represented as integer values, ranged from 0 to 6, and clusters of 3 or more risk factors occurred at twice the rate predicted by chance. After adjustment for age and obesity level, a 2.25-kg (5-lb) weight increase over 16 years was associated with an increased risk factor sum in men (+20%; P=.002) and women (+37%; P<.001), and a 2.25-kg weight loss was associated with a decreased risk factor sum in men (-48%; P<.001) and women (-40%; P<.001). Clusters of 3 or more risk factors were associated with a 2.39 (95% confidence interval, 1.56-3.36) and 5.90 (95% confidence interval, 2.54-13.73) times greater risk of coronary heart disease in men and women, respectively (both P<.001).
CONCLUSIONS: Atherogenic risk factor clustering is common in both sexes, worsens with weight gain, and is associated with greatly increased risk of coronary disease risk in both sexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335688     DOI: 10.1001/archinte.159.10.1104

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  129 in total

1.  HIV and general cardiovascular risk.

Authors:  Bernadette Capili; Joyce K Anastasi; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2011-02-01       Impact factor: 1.354

2.  The metabolic syndrome.

Authors:  James B Meigs
Journal:  BMJ       Date:  2003-07-12

Review 3.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 4.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

5.  Weight loss: a tool to reduce proteinuria.

Authors:  Zohreh Soltani; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

6.  Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects.

Authors:  Reza Meshkani; Hamzeh Saberi; Narges MohammadTaghvaei; Mohammad Amin Tabatabaiefar
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

Review 7.  Epidemiology of the insulin resistance syndrome.

Authors:  James B Meigs
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

8.  The factor structure of the metabolic syndrome in obese individuals with binge eating disorder.

Authors:  Tomoko Udo; Sherry A McKee; Marney A White; Robin M Masheb; Rachel D Barnes; Carlos M Grilo
Journal:  J Psychosom Res       Date:  2013-10-18       Impact factor: 3.006

9.  Long-term care in developed countries and recommendations for Slovak Republic.

Authors:  Mário Lezovic; Miroslava Raucinová; Andrej Kovác; Stefánia Moricová; Roman Kovác
Journal:  Cent Eur J Public Health       Date:  2008-03       Impact factor: 1.163

10.  Association between metabolic syndrome and gestational diabetes mellitus in women and their children: a systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Endocrine       Date:  2020-09-15       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.